# A Multi-center Clinical Study of Drug Antibody and Precision Transfusion in China

> **NCT05606302** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 14000 (estimated)

## Conditions studied

- Drug-specific Antibodies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05606302
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 14000 (ESTIMATED)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05606302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05606302, "A Multi-center Clinical Study of Drug Antibody and Precision Transfusion in China". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05606302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*